BTN2A1 and colorectal carcinoma: CRC-TAF are equipped to allow ZA, either soluble or driven by the ADC, to exert its effect: they express BTN2A1, and to a lesser extent BTN3A1 molecules that are needed for the exposure of PA in a molecular form recognizable by the Vδ2 TCR [26,27].